Guiding Drug Provocation Testing for Ibuprofen Hypersensitivity in a Pediatric Population: Development of the I3A Risk-Stratification Tool
We generated a risk-stratification tool to identify children at low risk of reacting to ibuprofen challenges. Further validation is required in external cohorts.
Authors
- Connor Prosty (ORCID: https://orcid.org/0000-0001-6790-220X)
- Judy Gaffar (ORCID: https://orcid.org/0000-0001-6233-8881)
- Ibtihal Al-Otaibi
- Angela Mulé
- Luca Delli Colli (ORCID: https://orcid.org/0000-0001-8728-2343)
- Derek Lanoue
- Moshe Ben‐Shoshan (ORCID: https://orcid.org/0000-0001-9083-1518)
- Ana Maria Copaescu (ORCID: https://orcid.org/0000-0002-9183-5032)
- Florian Stehlin (ORCID: https://orcid.org/0000-0003-1687-7811)
- Joshua Yu
Institutions
- Princess Nourah bint Abdulrahman University (SA)
- McGill University Health Centre (CA)
- Université de Montréal (CA)
- McMaster University (CA)
Publication Details
- Journal
- The Journal of Allergy and Clinical Immunology In Practice
- Published
- 2024-12-03
- DOI
- https://doi.org/10.1016/j.jaip.2024.11.022
- Citations
- 3
- Primary Topic
- Drug-Induced Adverse Reactions
- Type
- article
- Field-Weighted Citation Impact
- 1.34